The extension, released shortly before the flexibilities were set to expire at the end of 2025, gives regulators more time to ...

DEA extends telemedicine prescribing flexibilities through 2026, allowing remote controlled substance prescriptions without in-person visits.

The American Telemedicine Association announced that the U.S. Drug Enforcement Administration, or DEA, granted a 1-year ...

As providers become more comfortable with delivering care via telemedicine, telehealth, and digital health technologies, some are exploring services beyond low acuity consults. One area of opportunity ...

The third temporary extension, which prolongs the pandemic-era flexibilities through the end of 2025, is a relief for telehealth groups who had raised concerns about access to medications. During the ...

The Drug Enforcement Administration has extended flexibilities for remote prescribing of controlled substances through the end of 2024. Final telemedicine regulations are expected to be issued by the ...

Less than one month after the Biden administration’s announcement on January 20, 2023, declaring the end of the public health emergency (PHE) on May 11, 2023, the US Drug Enforcement Administration ...

More than seven years have passed since Michigan legislation aimed at combating the state’s opioid crisis took effect. Although subsequent guidance by state and federal agencies have provided some ...

Although 2022 has brought on a greater sense of normalcy, the past few years have distracted us from one of the most overlooked epidemics plaguing healthcare: prescription drug abuse. Before Covid-19 ...

In late February, the Drug Enforcement Administration announced a set of proposed rules that would roll back some of the flexibilities allowed during the pandemic for the prescribing of controlled ...

SAN ANTONIO--(BUSINESS WIRE)--Office Ally announced today the expansion of its highly acclaimed e-prescribing module to now provide for electronic prescribing of controlled substances. By achieving ...